ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-25 EDT			5-day change	1st Jan Change
1.830 ^USD	+0.55%		-3.17%	+0.55%

09-10	Alzamend Neuro, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
08-20	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

80288231316afbc4e071.s3N6V4nqEVfyxZbdARXFe-eodQNc2Z_8lUwAnLyRH8I.9RojPMGOUjakn-WnV0KWKaLPR0UUg-6vzyNO3-TJTbjwAigh3b1nYaiU2w~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

23-04-12	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
21-12-27	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
21-10-01	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,320.77%
	LONZA GROUP AG					+20.9%
	IQVIA HOLDINGS INC.					+3.4%
	REVOLUTION MEDICINES, INC.					+23.88%
	BEONE MEDICINES AG					+19.94%
	CELLTRION, INC.					+50.95%
	MEDPACE HOLDINGS, INC.					-5.99%
	TEMPUS AI, INC.					-19.36%
	EUROFINS SCIENTIFIC SE					-6.61%
	ASCENDIS PHARMA A/S					+37.6%
	Average					+144.55%
	Weighted average by Cap.					+17.07%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.830USD

Average target price

26.00USD

Spread / Average Target

+1,320.77%

High Price Target

26.00USD

Spread / Highest target

+1,320.77%

Low Price Target

26.00USD

Spread / Lowest Target

+1,320.77%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

The best tools reserved for subscribers to boost the performance of your investments!